Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.4 - $17.73 $1.27 Million - $1.68 Million
-94,791 Reduced 73.15%
34,798 $513,000
Q2 2024

Aug 09, 2024

BUY
$13.01 - $15.77 $118,820 - $144,027
9,133 Added 7.58%
129,589 $1.8 Million
Q1 2024

May 10, 2024

BUY
$14.06 - $16.79 $1.69 Million - $2.02 Million
120,456 New
120,456 $1.89 Million
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $405,554 - $595,815
33,379 Added 53.25%
96,062 $1.18 Million
Q2 2023

Aug 10, 2023

BUY
$14.1 - $19.83 $382,011 - $537,254
27,093 Added 76.13%
62,683 $1.01 Million
Q1 2023

May 15, 2023

SELL
$9.09 - $19.45 $154,575 - $330,747
-17,005 Reduced 32.33%
35,590 $619,000
Q4 2022

Feb 13, 2023

SELL
$6.45 - $12.07 $998,666 - $1.87 Million
-154,832 Reduced 74.64%
52,595 $485,000
Q3 2022

Nov 14, 2022

BUY
$7.86 - $12.91 $1.63 Million - $2.68 Million
207,427 New
207,427 $1.79 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.26B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.